Compare HRMY & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | SNDA |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2020 | 1997 |
| Metric | HRMY | SNDA |
|---|---|---|
| Price | $36.75 | $34.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $48.08 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 993.4K | 422.6K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.97 | N/A |
| EPS | ★ 1.84 | N/A |
| Revenue | ★ $868,453,000.00 | $381,141,000.00 |
| Revenue This Year | $18.17 | $120.42 |
| Revenue Next Year | $13.71 | $17.55 |
| P/E Ratio | $20.01 | ★ N/A |
| Revenue Growth | 21.51 | ★ 25.24 |
| 52 Week Low | $25.90 | $29.50 |
| 52 Week High | $43.49 | $44.39 |
| Indicator | HRMY | SNDA |
|---|---|---|
| Relative Strength Index (RSI) | 50.13 | 39.72 |
| Support Level | $36.74 | $32.95 |
| Resistance Level | $39.40 | $37.18 |
| Average True Range (ATR) | 1.50 | 1.08 |
| MACD | 0.17 | 0.10 |
| Stochastic Oscillator | 80.36 | 37.70 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.